AstraZeneca announces Rs 176 crore investments in India to expand Chennai GITC
AstraZeneca announces Rs 176 crore investments in India to expand Chennai GITC Written by Ruchika Sharma Published On 2025-09-08T11:36:46+05:30 | Updated On 8 Sept 2025 11:36 AM ISTChennai: Global biopharmaceutical giant AstraZeneca has announced fresh investments of Rs 176 crore in India, reinforcing its commitment to healthcare innovation and technology. The announcement was made during the Tamil Nadu government’s “TN Rising” campaign in London, coinciding with Chief Minister M.K. Stalin’s visit to the United Kingdom.The investment will expand the Global Innovation and Technology Centre’s infrastructure and capabilities to strengthen its position as a leader in healthcare innovation both globally and in India, a company statement said here on Saturday.It is the third investment by AstraZeneca after it announced investments of Rs 166 crore in June towards the establishment of a state-of-the-art Global Hub in Bengaluru.Read also: AstraZeneca expands Global Hub in Bangalore with Rs 166 crore investment In July 2024, AstraZeneca announced investments of Rs 250 crore towards expanding the Global Innovation and Technology Centre in Chennai.At an event on Friday, officials of AstraZeneca and Guidance, the Tamil Nadu government-backed investment promotion agency, exchanged documents in the presence of Stalin and Industries Minister TRB Rajaa among others, PTI reported.The GITC in the city would benefit immensely from upgraded and additional capacity designed to enable collaborative research and transformative solutions that address complex healthcare challenges.Read also: AstraZeneca Imfinzi application granted priority review by USFDA for resectable early stage gastric, gastroesophageal junction cancersastrazenecaastrazeneca newsinvestmentGuidanceSource : with inputsRuchika SharmaRuchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751Show Full ArticleNext Story